Eurazeo

Q1-24 : A sluggish start to the year

16/05/24 -"Although had been expecting private equity activity to pick up in 2024, Eurazeo’s Q1-24 performance failed to live up to expectations. While AUM were up by 8% yoy and held steady qoq, ..."

PDF page sample
Pages
52
Language
English
Published on
16/05/24
Download
You may also be interested by these reports :
02/07/26
sino AG unveiled fantastic results in H1 26 (October 2025-March 2026), with strong top-line growth as well as a significant improvement in ...
01/07/26
Our EPS for 2027 is positively impacted by the announced acquisition of a 20% stake in FMC. Indeed, the additional interest costs related to the ...
01/07/26
Tessenderlo announced a $400m minority investment in US-listed FMC Corporation specializing in pesticides, a move that would potentially redefine the ...
29/06/26
Prosus delivered another high-quality set of results, beating consensus across all major operating metrics while further improving profitability and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO